Department of Histology and Embryology, Center for Biostructure Research, Warsaw Medical University, Chałubińskiego 5, 02-004 Warsaw, Poland.
Mediators Inflamm. 2013;2013:289789. doi: 10.1155/2013/289789. Epub 2013 Jun 27.
Anticancer activity of many herbs was observed for hundreds of years. They act as modifiers of biologic response, and their effectiveness may be increased by combining multiple herbal extracts . PERVIVO, traditional digestive herbal remedy, contains some of them, and we previously described its antiangiogenic activity. Numerous studies documented anticancer effects of nonsteroidal anti-inflammatory drugs. We were the first to show that sulindac and its metabolites inhibit angiogenesis. In the present paper the combined in vivo effect of multicomponent herbal remedy PERVIVO and nonsteroidal anti-inflammatory drug sulindac on tumor growth, tumor angiogenesis, and tumor volume in Balb/c mice was studied. These effects were checked after grafting cells collected from syngeneic sarcoma L-1 tumors into mice skin. The strongest inhibitory effect was observed in experimental groups treated with PERVIVO and sulindac together. The results of our investigation showed that combined effect of examined drugs may be the best way to get the strongest antiangiogenic and antitumor effect.
许多草药的抗癌活性已经被观察了数百年。它们作为生物反应调节剂,通过联合使用多种草药提取物可以提高其疗效。PERVIVO 是一种传统的消化草药疗法,其中包含一些草药,我们之前曾描述过其抗血管生成活性。大量研究记录了非甾体抗炎药的抗癌作用。我们是第一个证明舒林酸及其代谢物抑制血管生成的人。在本文中,研究了多成分草药疗法 PERVIVO 和非甾体抗炎药舒林酸对 Balb/c 小鼠肿瘤生长、肿瘤血管生成和肿瘤体积的体内联合作用。这些作用是在将来自同源肉瘤 L-1 肿瘤的细胞移植到小鼠皮肤后检查的。在同时接受 PERVIVO 和舒林酸治疗的实验组中观察到最强的抑制作用。我们的研究结果表明,检查药物的联合作用可能是获得最强的抗血管生成和抗肿瘤作用的最佳方法。